Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Satellos Bioscience Inc.

MSCL
Current price
0.87 CAD -0.02 CAD (-2.25%)
Last closed 0.89 CAD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Toronto Exchange
Capitalization 105 909 003 CAD
Yield for 12 month +112.20 %
1Y
3Y
5Y
10Y
15Y
MSCL
21.11.2021 - 28.11.2021

Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of Duchenne. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada. Address: Royal Bank Plaza, Toronto, ON, Canada, M5J 2J1

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.58 CAD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-8 838 705 CAD

Last Year

-3 743 193 CAD

Current Quarter

Last Quarter

-5 952 618 CAD

Key Figures MSCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 723 167 CAD
Operating Margin TTM
PE Ratio
Return On Assets TTM -37.20 %
PEG Ratio
Return On Equity TTM -58.84 %
Wall Street Target Price 1.58 CAD
Revenue TTM
Book Value 0.36 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.25 CAD
Diluted Eps TTM -0.25 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MSCL

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - ожидаемая <5 дивидендная доходность по себестоимости за 10 лет MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History MSCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 18.08.2021
Dividend Date

Stock Valuation MSCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 6.4674
Price Book MRQ 5.1318

Financials MSCL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MSCL

For 52 weeks

0.38 CAD 1.32 CAD
50 Day MA 0.79 CAD
Shares Short Prior Month 15 528
200 Day MA 0.58 CAD
Short Ratio 0.04
Shares Short 8 429
Short Percent